跳至主要内容
临床试验/NCT06176274
NCT06176274尚未招募不适用

The Effect of Pre-Operative Prehabilitation Program on Postoperative Recovery in Women With Gynecological Cancer

Istanbul University - Cerrahpasa (IUC)2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
2
主要终点
the WHODASS proficiency scale

研究概览

简要总结

The aim of this study is to determine the effect of the prehabilitation program applied to postmenopausal women diagnosed with gynecological cancer before surgery on postoperative recovery, planned as a randomized study with an experimental design with a pre-test post-test control group.

详细描述

The aim of prehabilitation programs is to eliminate intraoperative complications by increasing the functional capacity and metabolic reserves of patients before surgical treatment and to accelerate recovery in the postoperative period. In addition, it helps the patient to maximize the existing capacity of the patient before the surgery, to know what will happen at each stage of the treatment to be applied to the patient, to feel better physically and spiritually and to understand the roles and responsibilities of the individual care of the patient, as well as making a significant contribution to the positive results of the operation. It is to provide exercise, psychological support, nutritional counseling and optimization of the underlying conditions by stopping negative health behaviors. There are non-eliminable criteria such as age, gender, comorbid diseases before surgery, as well as modifiable factors such as the regulation of the patients nutrition, ensuring psychological well-being, quitting smoking. In particular, some factors directly affect the state of well-being during the perioperative period. Thus, surgeries become safer.As a practice, the prehabilitation program (according to the surgery program) is planned in the preoperative period between 2-4 weeks Dec. Participants who do not comply with the program will be excluded from the sample

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

盲法说明

the experimental group will receive care through the prehabilitation program, while the control group will receive standard nursing care. participants will not know which group they are in.

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients who are not stage 4 in preoperative evaluation
  • Who volunteered to participate in the study
  • 6 months have passed since the last treatment (Chemoretapy, Radiotherapy)
  • Women who do not have Turkish literacy problems
  • Women aged 50 and older who are in the postmenopausal period
  • Patients who are scheduled for abdominal surgery

排除标准

  • High-risk comorbid diseases such as COPD, heart failure
  • Physical and mental conditions that will interfere with nutrition and exercise
  • Those with orthopedic and neuromuscular diseases
  • Those who are scheduled for surgery by laparoscopic/laparotomic method
  • Those who cannot adapt to the program during the preoperative period
  • Women who are too depressed during preoperative evaluation

结局指标

主要结局

the WHODASS proficiency scale

时间窗: 1 weeks

the WHODASS proficiency scale will be used. It is useful for a brief assessment of the overall functionality.

the Quality of Recovery QoR-15

时间窗: 6 weeks

The scale is based on the assumption that the higher the score, the better the quality of improvement when measuring between 0 and 150 points. The scale is based on the assumption that the higher the score, the better the quality of Deceleration.

functional capacity 6MWT

时间窗: 10 weeks

6MWT has also been used to determine the functional status of patients . During the test, a standardized protocol is followed by walking on a flat floor for 6 minutes. It is a self-paced test and is a repeatable, cheap and easy test (unlike the increasingly brisk walking tests that require intervention).

day of hospital stay

时间窗: 1 weeks

the length of hospital stay

次要结局

未报告次要终点

研究者

发起方
Istanbul University - Cerrahpasa (IUC)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hilal Evgin

Principal Investigator

Istanbul University - Cerrahpasa (IUC)

研究点 (2)

Loading locations...

相似试验